Distal Renal Tubular Disorders Flashcards
what are two Na+ wasting disorders in the distal tubule?
- Bartter Syndrome
- Gitelman Syndrome
What distal tubule disorder causes HTN because of a defect in Na+ transport?
Liddle Syndrome
What percentage of Na+ is absorbed in the following areas?
- Proximal Tubule
- TALH
- Distal Tubule
- Collecting duct
Proximal Tubule = 65-70%
TALH = 25%
Distal Tubule = 5%
Collecting Duct = 1-2%
What is targeted by Acetazolamide and where?
Carbonic Anhydrase
- Proximal Convoluted Tubule
What is targeted by Furosemide?
- other drugs in this class?
Bumetanide, Ethacrynic Acid
- NK2C cotransporter in the TALH
What is targeted by Thiazides?
- where?
NC cotransporter in the Distal Convoluted tubule
What is the targeted by Amiloride?
- where?
- other drugs in this class?
Amiloride and Triamterene are in the same class
- ENaC **DCT and CD (I think the CD is more heavily targeted)
What is targeted by Spironolactone?
- other drugs in class?
- where?
Mineralcorticoid Receptor in the CD Eplerenone
General Bartter Syndrome (applicable to both types)
- 4 possible mutation?
- What are some key features of this syndrome?
- Inheritance?
- Treatment?
Mutations - AUTOSOMAL RECESSIVE:
Bumetanide-sensitive Na+-K+-Cl-cotransporter (NK2C - cotransporter), ATP-sensitive K+ channel (ROMK), Cl- channel A subunit (CLCNKA), Cl- channel B subunit (CLCNKB)
KEY FEATURES
- HYPOkalemia / HYPERaldosteronism => Hyperrreninemia
- HYPOcloremic metabolic alkalosis
- Kidneys showed hyperplasia of the juxtaglomerular apparatus
- Elevated plasma renin and aldosterone
Treatment: K+ supplements, Mg2+ supplements (if needed)
Differentiate Neonatal Bartter Syndrome and Classic Bartter Syndrome
- Common Features
- Key Differences
Common Features:
- Failure to Thrive
- Hypercalciuria
- Episodes of Dehydration
Key Differences:
NEONATAL - Polyhydramios, Preterm Delivery, NEPHROCALCINOSIS, HEARING LOSS
Classic - hypercalciurea but NO nephrocalcinosis
Gitelman Syndrome
- mutation, where?
- What are some key features of this syndrome?
Mutation:
AUTOSOMAL RECESSIVE mutation in NC (thiazide sensitive) Co-transpoerter on the LUMINAL side of the DISTAL CONVOLUTED TUBULE
Features:
HYPOkalemia and Hypochloremic Metabolic Alkalosis
May present with Dehydration and Tetany
HYPOcalicurecemia
What are some key distinguishing features between Bartter’s and Gitelman Syndrome?
- how does this relate to the nature of their mutation?
Bartter’s:
- HYPERcalciuria
- Mutation is in the TALH (NK2C, ROMK, or Cl- channel) which is MORE IMPORTANT for Na+ absorption - so deficiency here is more severe and disease is more severe…
- Failure to Thrive is more common
Gitelman’s Syndrome:
- *- HYPOcalciuria
- HYPERmagnesuria**
- Mutation is in the TSC/ NC cotransporter DCT which is less important for Na+ absorptoin
******All these syndromes of hypochloremic metabolic alkalosis have been associated with hyperplasia of the juxtaglomerular apparatus.
********Several other syndromes of hypochloremic metabolic alkalosis (chronic vomiting, diuretic abuse, congenital chloride diarrhea, cystic fibrosis, ingestion of formula deficient in chloride) can mimic Bartter and Gitelman syndrome. How might you distinguish them?
- *Liddle Syndrome**
- Mutation/inheritance?
- Clinical Disorder caused by mutation?
- Treatment?
Mutation:
- AUTOSOMEAL DOMINANT Gain of Function mutation in the Beta or Gamma subunit of Epithelial Sodium Channel ENaC
- *Clinical Disorder:
- Hyperabsorption of Na+ b/c of XS ENaC leads toHYPOkalemic Metabolic Alkalosis**
What happens when AVP binds the AVP-receptor?
- what specific receptor is most important?
AVPR2 receptor aka V2 receptors - its a GPCR
- causes cAMP release and PKA activation which phosphorylates vesicles and triggers them to fuse with the cell membrane
Why would hyperaldosteronsim and use of Diuretics lead to hypokalemia?
- *Diuretics:**
- Increase Na+ concentration in the Collecting Duct
- more exchange of Na+ through ENaC and potassium out of ROMK leads to increased K+ secretion
- *Hyperaldosteronism:**
- Increase of ENaC, ROMK, NKA, etc.
- More channels will favor the already favorable Na+ uptake
- *Nephrogenic Diabetes Insipidus (NDI)**
- Mutation(s)/ Inheritance(s)
- Pathophysiology
- DDx technique
Mutations:
- *AVPR2 (RECEPTOR MUTATION)** - X-linked point mutations (XQ28)= 90%
- *AQUAPORIN-2** - Autosomal Recessive = 10%
Pathophysiolgy:
- *LOW urine Osmolarity** - b/c aquaporins are needed to concentrate the urine
- *CRAZY HIGH THIRST** - PLASMA osmolarity is HIGH water is not being reabsorbed
DDx:
- This and Central Diabetes Insipidus present the same way except a person with Nephrogenic Diabetes insipidus should be responsive to ADH/DDAVP injection
How do patients with NDI (nephrogenic diabetes insidpidus) present?
- additional problems in infants?
- Treatment?
Symptoms:
- Polydipsia, Polyuria, Irritability, Constipation
- Formula Intolerance with Vomiting, Failure to Thrive, Hyperthermia
Signs:
- Hydronephrosis
- Megaureter
- Bladder Dysfunction
Infants:
- Severe dehydration can lead to hypoperfusion of the Brain, Kidneys
- may cause MENTAL RETARDATION and Renal Damage
TREATMENT:
- *- Abudnant Free Water Intake
- Low Solute Diet
- Diuretics**
What diuretics are typically used in nephrogenic diabetes insipidus?
- what is the point of using diuretics to treat these patients?
Diuretics:
- Amiloride and Hydrochlorothiazide
Purpose:
- Reduce Obligatory urine ouput to prevent episodes of Dehydration (leading to reduced risk of mental retardation)
What is Glucocorticoid-Remediable Hyperaldosteronism (GRA)?
- Mutation?
- Pathiophysiology/disease caused? (hyper/hypo kalemia/natremia etc.)
- Treatment?
Mutation:
- Results from the recombination of the homologous genes for 11-beta-hydroxysteroid dehydrogenase (11betaHSD) and aldosterone synthase
Pathophysiology:
- Gene pdt. = hybrid molecule that MAKES ALDOSTERONE in response to STRESS
- causes LOW RENIN HTN and HYPOKALEMIA
Treatment:
- Physiologic doses of Glucocorticoids
- *Apparent Mineralocorticoid Excess**
- Mutation
- Pathophsiology? (hyper/Hypo kalemia/natremia etc.)
- Treatment?
Mutation:
- Kidney isozyme of 11betaHSD
Pathophysiology:
- increased levels of cortisol in the kidney cross-reacts and **activates the mineralcorticoid receptor
- causeslow renin HTN, andHYPOKalemia**
Treatment:
- Physiologic Doses of Glucocorticoids
How do Hypoaldosteronism and Pseudohypoaldosteronism come about?
- do they cause hypo or hyperkalemia?
- *Hyperaldosteronism:**
- Congenital Adrenal Hypoplasia
- Congenital Adrenal Hyperplasia
- Autoimmune
- *Pseudohypoaldosteronism (PHA):**
- PHA Type I
- PHA Type II
- Tubular Injury (obstructive uropathy)
*****BOTH CAUSE HYPERKALIEMIA******
What syndrome is the “mirrow image” of Liddle syndrome?
• Why can we say this?
Pseudohypoaldosteronism (PHA) type I
Characterized by:
- *1. Hyperkalemia
2. Hyponatremia**
3. Prone to severe volume depletion and HYPOTENSION
What is the inheritance of PHA type I?
• Treatment?
- *PHA type I - Any Type of Inheritance**
- *• Recessive Form** = ENaC mutation (explains the hyperkalemia with Hyponatremia)
Treatment:
• High Salt Diet, Prompt Fluid Resusciation (Na+ containing fluids are used in the case of volume depletion), K+ Binding Resin May also be Needed
PHA (pseudohypoaldosteronism) Type II
• AKA?
• Genetic Defect/Pathophysiology?
• Area of filtration system affected?
PHA II aka Gordon Syndrome
Genetic Defect:
• WNK1 and WNK4 are mutated leading to INCREASED absorption into the Elecroneutral Na/Cl transporter in the Distal Convoluted Tubule
Pathophysiology:
• Result is excessive Na+ reabsorption and HTN
• K+ secretion is reducedbecause less Na+ is delivered to collecting duct